Atara Biotherapeutics, Inc. (ATRA)
NASDAQ·Healthcare·Biotechnology
$9.86
+2.50%
Mkt Cap $40.81M
Analyst Ratings
Buy
2
Hold
2
Sell
1
Price Target (7 analysts)
$9.50
Range $6.00 – $13.00
Implied Upside
-3.7%
Consensus $9.50 vs current $9.86
NASDAQ·Healthcare·Biotechnology
$9.86
+2.50%
Mkt Cap $40.81M
Buy
2
Hold
2
Sell
1
Price Target (7 analysts)
$9.50
Range $6.00 – $13.00
-3.7%
Consensus $9.50 vs current $9.86